Lipids & metabolic liver disease

Liver Stiffness Measurement and All-Cause Mortality in Individuals With Diabetes

JAMA Netw OpenPublished Cohort study

Authors' conclusion

In this cohort study, LSM was an independent risk factor for all-cause mortality in individuals with diabetes, even after a relatively short follow-up. Implementing LSM to screen for liver fibrosis as part of routine diabetes management could aid in early identification of patients with high mortality risk.

Study context

Population
Adults with complete vibration-controlled transient elastography (VCTE) and controlled attenuation parameter (CAP) data, NHANES 2017–2018, linked to National Death Index to December 31, 2019; liver disease other than MASLD excluded; mean (SEM) age 47 (1) years, 50.7% female, 14.5% with diabetes
Participants
4,102 adults
Exposure
Diabetes with MASLD or advanced liver fibrosis vs without
Outcome
All-cause mortality (hazard ratios (HRs) with 95% CIs, Cox proportional hazards regression)
Follow-up
Mean (SEM) 24 (2) months
Methodological detailscomplex survey design with examination weights, Cox proportional hazards regression, Data analyzed from December 2024 to December 2025
  • Complex survey design with examination weights
  • Cox proportional hazards regression
  • Data analyzed from December 2024 to December 2025

Main finding

As reported in the abstract

All-cause mortality

Died during follow-up

59 patients

1.4%

Coexistence of diabetes with MASLD (CAP ≥274 dB/m), aHR

2.77

95% CI 1.16–6.65P = .03

Diabetes with advanced liver fibrosis (liver stiffness measurement (LSM) ≥9.7 kPa), aHR

6.41

95% CI 1.03–39.85P = .047

In patients with diabetes, LSM associated with all-cause mortality after adjustment (age, sex, body mass index (BMI), HbA1c), aHR

1.06

95% CI 1.04–1.09P < .001

Observational data: associations, not effects.

Further findings

Characteristics of patients who died vs did not

Mean (SEM) age, died vs not (P < .001)
62 [3] years vs 47 [1] years
Prevalence of diabetes, died vs not (P = .01)
35.7% vs 14.2%
Non-Hispanic White race, died vs not (P = .002)
85.1% vs 62.7%

Original publication

Liver Stiffness Measurement and All-Cause Mortality in Individuals With Diabetes. JAMA Netw Open. Published 2 March 2026. doi:10.1001/jamanetworkopen.2026.0762

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.